|
|
U.S. qRT-PCR MarketsPublished by: Frost & Sullivan Published: Oct. 5, 2006 - 89 Pages Table of Contents
1. Market Overview 1. Introduction 2. Total U.S. qRT-PCR Market 1. Market Overview 1. Introduction 2. Scope and Segmentation 3. Research Methodology 4. Market Engineering Measurements 2. Industry Challenges and Strategic Recommendations 1. Industry Challenges 2. Strategic Recommendations 3. Competitive Structure and Product Analysis 1. Competitive Structure 2. Acquisitions and Strategic Partnerships 3. Product Analysis 4. Revenue Forecasts and Market Share Analysis 1. Revenue Forecasts 2. Market Share Analysis 3. qRT-PCR Instrumentation Market 1. Market Overview 1. Introduction 2. Market Engineering Measurements 2. Market Drivers and Restraints 1. Market Drivers a. Paradigm Shift of Research Creates Demand for qRT-PCR Instruments b. Lower Prices for qRT-PCR Instruments Drives Demand c. Expansion into Clinical Markets for Therapeutic Monitoring and as a Type of Therapy Increases Potential for qRT-PCR Instrumentation Market d. Multiplexing Creates Efficiencies in Research Experiments, Promoting the Use of qRT-PCR as a Viable Research Methodology e. Sample Handling Automation Promotes qRT-PCR Instrumentation Purchases for High Volume Analysis f. Lack of Competing Technologies/Products Necessitates Use of qRT-PCR for Comparative Genetic Analysis 2. Market Restraints a. qRT-PCR Licensing Fees Restrict Entrance of New Competitors to the Market, Resulting in Higher Prices for Instruments b. Low Replacement Rates for qRT-PCR Instrumentation Limits Potential for Market Growth c. Automation Reduces the Need for Multiple qRT-PCR Instruments d. Alternative Approaches may Supplant the Need for qRT-PCR Instruments e. Multiplexing Requires Reaction Conditions that are Difficult to Determine, Thereby Stifling the Use of qRT-PCR in Research Studies and Decreasing Demand for Instruments 3. Technology and Market Trends 1. Technology Trends 2. Market Trends 4. Competitive Structure and Product Analysis 1. Competitive Structure 2. Product Analysis 5. Revenue Forecasts and Market Share Analysis 1. Revenue Forecasts 2. Market Share Analysis 4. qRT-PCR Reagents Market 1. Market Overview 1. Introduction 2. Market Engineering Measurements 2. Market Drivers and Restraints 1. Market Drivers 2. Market Restraints 3. Technology and Market Trends 1. Technology Trends 2. Market Trends 4. Competitive Structure and Product Analysis 1. Competitive Structure 2. Product Analysis 5. Revenue Forecasts and Market Share Analysis 1. Revenue Forecasts 2. Market Share Analysis 5. Decision Support Databases 1. Decision Support Databases 1. Number of Biotechnology Companies 2. Private Investment in Biotechnology 3. Government Biotechnology R&D Investment 4. Total Healthcare Expenditures List of Figures Chapter 2 Chapter 3 Chapter 4 AbstractResearch OverviewThis Frost & Sullivan research service titled U.S. qRT-PCR Markets provides a market forecast for qRT-PCR instruments and reagents, by analyzing applications, high installed base of instruments, and the restraints to market growth instituted by patent protection of key technologies. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: qRT-PCR instrumentation and qRT-PCR reagents. Market Sectors Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:
The following technology is covered in this research:
Integration of qRT-PCR Technologies in Research and Clinical Applications is Revolutionizing Healthcare The use of quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) technology is revolutionizing the healthcare industry. The market for qRT-PCR products is poised for significant growth with increasing use of the technology seen in the life sciences research and medical industries. The technology provides an efficient means to monitor the expression levels of multiple genetic messages in real-time, thereby assisting scientists involved in the discovery of biomarkers and development of new drugs. Clinical applications of qRT-PCR technologies include diagnostic evaluation, such as drug regimen efficacy assays, and ribonucleic acid interference (RNAi) and small interfering (si) RNA techniques that serve as therapies themselves. "Information on a cell's response to stimuli in real-time is being exploited to enhance fundamental knowledge of disease development, and it provides a distinct point in the disease cycle where therapeutic intervention and treatment assessment is possible,” observes the analyst of this research service. “This is likely to give significant impetus to the qRT-PCR market, stimulating growth through 2012.” Emerging Trends in qRT-PCR Technology Strengthen Market Growth Potential Market participants can receive substantial and stable returns from the thinly dominated qRT-PCR market, especially from the rapidly growing reagents segment. Adoption of qRT-PCR by additional users is likely to accelerate market growth as the technology matures. To gain a successful position in the market, manufacturers are proactively involved in instrument design and reagent optimization. Quick analyses, coupled with multiplexing capabilities, allow simultaneous screening of multiple messages. “As the qRT-PCR multiplexing instrument market is still relatively new, initial purchases of these instruments may essentially drive the demand,” notes the analyst. There are opportunities for market participants to create additional color schemes that can increase the number of signals monitored with multiplexing instruments to provide a way to monitor all signals in a related pathway. Manufacturers are producing longer lasting thermostable qRT-PCR reagents that can withstand room temperature for as long as 24 hours, thereby allowing full use of the instrument even when laboratory personnel are not present. In addition, the development of signaling pathway specific kits, and identification of threshold levels of expression that signify physiological changes, will appeal to translational research scientists in their efforts to create tests for clinical use. Manufacturers are making their products available at affordable prices to cater to budget-constrained research groups. The need for robust products with enhanced capabilities is likely to offer growth opportunities to smaller market participants. Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||